Genus PLC
LSE:GNS
Genus PLC
LSE:GNS
Price:
1 820 GBX
-0.22%
Updated:
Jun 7, 2024
Genus PLC
Other Operating Expenses
|
Genus PLC
Other Operating Expenses Peer Comparison
Comparables:
CNTA
EXAI
AUTL
BCYC
IMCR
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Genus PLC
LSE:GNS
|
Other Operating Expenses
-£606.7m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Other Operating Expenses
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Exscientia PLC
NASDAQ:EXAI
|
Other Operating Expenses
£6.6m
|
CAGR 3-Years
63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Genus PLC's Other Operating Expenses?
Other Operating Expenses
-606.7m
GBP
-606.7m
GBP
Based on the financial report for Dec 31, 2023, Genus PLC's Other Operating Expenses amounts to -606.7m GBP.
What is Genus PLC's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 10Y
-7%
-7%
Over the last year, the Other Operating Expenses growth was -3%. The average annual Other Operating Expenses growth rates for Genus PLC have been -6% over the past three years , -8% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
